324 related articles for article (PubMed ID: 25562321)
1. Telomerase mutations in smokers with severe emphysema.
Stanley SE; Chen JJ; Podlevsky JD; Alder JK; Hansel NN; Mathias RA; Qi X; Rafaels NM; Wise RA; Silverman EK; Barnes KC; Armanios M
J Clin Invest; 2015 Feb; 125(2):563-70. PubMed ID: 25562321
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and the Genetics of Emphysema Susceptibility. Implications for Pathogenesis Paradigms and Patient Care.
Stanley SE; Merck SJ; Armanios M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5(Suppl 5):S447-S451. PubMed ID: 28005428
[TBL] [Abstract][Full Text] [Related]
3. Telomerase mutations in families with idiopathic pulmonary fibrosis.
Armanios MY; Chen JJ; Cogan JD; Alder JK; Ingersoll RG; Markin C; Lawson WE; Xie M; Vulto I; Phillips JA; Lansdorp PM; Greider CW; Loyd JE
N Engl J Med; 2007 Mar; 356(13):1317-26. PubMed ID: 17392301
[TBL] [Abstract][Full Text] [Related]
4. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Katzenstein AL; Godwin JD; Raghu G; Glazer CS; Rosenblatt RL; Girod CE; Garrity ER; Xing C; Garcia CK
PLoS One; 2010 May; 5(5):e10680. PubMed ID: 20502709
[TBL] [Abstract][Full Text] [Related]
5. Telomere length is a determinant of emphysema susceptibility.
Alder JK; Guo N; Kembou F; Parry EM; Anderson CJ; Gorgy AI; Walsh MF; Sussan T; Biswal S; Mitzner W; Tuder RM; Armanios M
Am J Respir Crit Care Med; 2011 Oct; 184(8):904-12. PubMed ID: 21757622
[TBL] [Abstract][Full Text] [Related]
6. Adult-onset pulmonary fibrosis caused by mutations in telomerase.
Tsakiri KD; Cronkhite JT; Kuan PJ; Xing C; Raghu G; Weissler JC; Rosenblatt RL; Shay JW; Garcia CK
Proc Natl Acad Sci U S A; 2007 May; 104(18):7552-7. PubMed ID: 17460043
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.
Stanley SE; Gable DL; Wagner CL; Carlile TM; Hanumanthu VS; Podlevsky JD; Khalil SE; DeZern AE; Rojas-Duran MF; Applegate CD; Alder JK; Parry EM; Gilbert WV; Armanios M
Sci Transl Med; 2016 Aug; 8(351):351ra107. PubMed ID: 27510903
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening in familial and sporadic pulmonary fibrosis.
Cronkhite JT; Xing C; Raghu G; Chin KM; Torres F; Rosenblatt RL; Garcia CK
Am J Respir Crit Care Med; 2008 Oct; 178(7):729-37. PubMed ID: 18635888
[TBL] [Abstract][Full Text] [Related]
9. The genetics and clinical manifestations of telomere biology disorders.
Savage SA; Bertuch AA
Genet Med; 2010 Dec; 12(12):753-64. PubMed ID: 21189492
[TBL] [Abstract][Full Text] [Related]
10. Short telomeres in pulmonary fibrosis: from genetics to clinical significance.
Trăilă D; Mlădinescu OF; Oancea C; Tudorache V
Pneumologia; 2015; 64(1):8, 11-3. PubMed ID: 26016050
[TBL] [Abstract][Full Text] [Related]
11. Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.
Alder JK; Cogan JD; Brown AF; Anderson CJ; Lawson WE; Lansdorp PM; Phillips JA; Loyd JE; Chen JJ; Armanios M
PLoS Genet; 2011 Mar; 7(3):e1001352. PubMed ID: 21483807
[TBL] [Abstract][Full Text] [Related]
12. Telomeres in lung diseases.
Calado RT
Prog Mol Biol Transl Sci; 2014; 125():173-83. PubMed ID: 24993703
[TBL] [Abstract][Full Text] [Related]
13. Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Yilmaz C; Brewington C; Wang R; Xing C; Hsia CCW; Garcia CK
Chest; 2011 Sep; 140(3):753-763. PubMed ID: 21349926
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of telomere length testing in a hospital-based setting.
Alder JK; Hanumanthu VS; Strong MA; DeZern AE; Stanley SE; Takemoto CM; Danilova L; Applegate CD; Bolton SG; Mohr DW; Brodsky RA; Casella JF; Greider CW; Jackson JB; Armanios M
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2358-E2365. PubMed ID: 29463756
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.
Borie R; Tabèze L; Thabut G; Nunes H; Cottin V; Marchand-Adam S; Prevot G; Tazi A; Cadranel J; Mal H; Wemeau-Stervinou L; Bergeron Lafaurie A; Israel-Biet D; Picard C; Reynaud Gaubert M; Jouneau S; Naccache JM; Mankikian J; Ménard C; Cordier JF; Valeyre D; Reocreux M; Grandchamp B; Revy P; Kannengiesser C; Crestani B
Eur Respir J; 2016 Dec; 48(6):1721-1731. PubMed ID: 27836952
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
van der Vis JJ; van der Smagt JJ; van Batenburg AA; Goldschmeding R; van Es HW; Grutters JC; van Moorsel CHM
Respirology; 2021 Dec; 26(12):1160-1170. PubMed ID: 34580961
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
18. Telomeres in lung disease.
Gansner JM; Rosas IO
Transl Res; 2013 Dec; 162(6):343-52. PubMed ID: 23618685
[TBL] [Abstract][Full Text] [Related]
19. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and idiopathic pulmonary fibrosis.
Armanios M
Mutat Res; 2012 Feb; 730(1-2):52-8. PubMed ID: 22079513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
